severe adverse event

SinoVac's Clinical Trials Resume in Brazil After the Death of Volunteer Was Confirmed to be Unrelated to the Vaccine

Anvisa Gives Green Light to SinoVac For Clinical Trials to Resume

Medicine & Technology Nov 12, 2020

SinoVac is the third pharmaceutical company to halt and resume clinical trials after a volunteer suffered a severe adverse event.

Sinovac Clinical Trials Halted in Brazil Due to a Severe Adverse Event

CoronaVac Phase Three Trials in Brazil Paused

Nov 10, 2020

Clinical trials are temporary on hold in Brazil after a volunteer experienced a severe adverse event.

Severe Adverse Event of One Volunteer Puts Oxford Vaccine Trials on Hold

AstraZeneca Temporarily Stops Phase 3 of Global Vaccine Trials

Sep 09, 2020

AstraZeneca, already in the late-stage of their phase three vaccine trials, had to pause all trials due to one volunteer developing an unexplained illness. Alongside other Operation Warp Speed Companies, the biopharmaceutical company signed a joint pledge to properly follow scientific and ethical standards in developing a coronavirus vaccine.